
07/25/2025
Many patients with early-stage CKD remain undiagnosed, and medicine-related risks often go unrecognised. A quick screening can be the crucial first step toward a more comprehensive assessment.
Here is how Nova Max Pro™ supports early kidney health detection:
▪ Faster kidney function screening at the point of care
▪ Improved access to timely results that guide clinical decisions
▪ Greater confidence in identifying early signs of CKD
We’re showcasing Nova Max Pro™ at PSA 2025, ICC Sydney, 1-3 August 2025. Pharmaceutical Society of Australia
Meet us at Booth 14 to explore a smarter, faster approach to kidney function testing with Nova Max Pro.